Pneumonia News and Research

Latest Pneumonia News and Research

Chronic obstructive pulmonary disease-related problems hard to swallow

Patients with moderate to severe chronic obstructive pulmonary disease (COPD) exhibit a disordered breathing-swallowing pattern that may account for their higher risk of aspiration pneumonia, according to new research from the University of Pittsburgh.

29 Mar 2009

Sagent Pharmaceuticals receives FDA approval of Azithromycin for injection

Sagent Pharmaceuticals, Inc. has announced U.S. Food and Drug Administration (FDA) approval of azithromycin for injection, a semi-synthetic, macrolide antibiotic that is used to treat a wide variety of bacterial infections. Sagent will offer azithromycin in a 500 mg vial for intravenous use.

26 Mar 2009

FDA approves new indication for Wyeth's Tygacil (tigecycline)

Wyeth Pharmaceuticals, a division of Wyeth has announced that the U.S. Food and Drug Administration (FDA) approved Tygacil (tigecycline), for the treatment of adult patients with community-acquired bacterial pneumonia (CABP) caused by susceptible strains of indicated pathogens.

24 Mar 2009

Novel anti-inflammatory therapy protects lungs from runaway inflammation

A novel anti-inflammatory therapy designed by Vanderbilt University Medical Center investigators prevents acute lung injury in mice exposed to an inflammation-causing toxin, the researchers report in the journal Molecular Therapy.

11 Mar 2009

Racial disparities in ER length of stay point to added risks for minority patients

Sick or injured African-American patients wait about an hour longer than patients of other races before being transferred to an inpatient hospital bed following emergency room visits, according to a new national study published in the journal Academic Emergency Medicine.

5 Mar 2009

European Commission and US FDA approve intravenous formulation of temozolomide

Schering-Plough Corporation (NYSE:SGP) today announced that the European Commission and the US FDA both approved the intravenous (IV) formulation of temozolomide as an alternative to the already approved oral form of the drug.

5 Mar 2009

Oseltamivir-resistant influenza A virus potentially serious to high-risk patients

A mutation of the influenza A(H1N1) virus that is resistant to the drug oseltamivir may pose a serious health threat to hospitalized patients who have a weakened immune system, according to a study to be published in the March 11 issue of JAMA, the Journal of the American Medical Association, and being released early online because of its public health importance.

2 Mar 2009

Wyeth's Prevenar vaccine for pneumococcal disease registered in Russia

Wyeth announced today that its 7-valent pneumococcal conjugate vaccine, Prevenar (Pneumococcal saccharide conjugated vaccine, Adsorbed), has been registered by the Russian Ministry of Health and Social Development (Roszdravnadzor) and is expected to be commercially available later this year.

2 Mar 2009

Bacteria-killing enzyme cures mice with fatal pneumonia

Before the advent of antibiotics, pneumonia claimed so many lives - and was so feared - that it was called the "captain of the ship of death."

1 Mar 2009

For psychiatric services, wait for the beep

Two-thirds of patients referred for psychiatric services following an emergency room visit are likely to reach only an answering machine when they call for help, compared to about 20 percent of patients calling medical clinics with physical symptoms.

25 Feb 2009

Doors open soon at new $360 million hospital with all-private rooms

When the doors to the new Henry Ford West Bloomfield Hospital open March 15, patients, their families and the community will find a health care experience unlike any other, offering the latest in medicine, technology and patient safety, integrated with wellness and prevention programs all under one roof.

25 Feb 2009

Implicit licenses clinical stage antibody program from Lilly

Implicit Bioscience Ltd has announced the acquisition of the clinical-stage monoclonal antibody IC14 from Eli Lilly and Company. Implicit has paid an undisclosed consideration combining cash and stock to Lilly. Lilly will also receive a royalty on future IC14 sales.

25 Feb 2009

Scientists manipulate bacteria into generating their own vaccine

Scientists have developed a way to manipulate bacteria so they will grow mutant sugar molecules on their cell surfaces that could be used against them as the key component in potent vaccines.

23 Feb 2009

Long-term use of inhaled corticosteroid drugs increases risk of pneumonia for COPD patients

Newly published research out of Wake Forest University School of Medicine finds that a popular class of anti-inflammatory inhalers significantly increases the risk of pneumonia in patients with Chronic Obstructive Pulmonary Disease (COPD).

9 Feb 2009

Emergency physicians question antibiotic guidelines for pneumonia

A new study from Wake Forest University Baptist Medical Center that assessed emergency physicians understanding of time-based, antibiotic treatment guidelines for community-acquired pneumonia (CAP) found that more than half believed they prescribed antibiotics needlessly in order to comply with guidelines.

8 Feb 2009

Many neglected diseases lacking research funding

The first comprehensive survey of global spending on neglected disease R&D, published in this week's PLoS Medicine , finds that just over $US 2.5 billion was invested into R&D of new products in 2007, with three diseases-HIV/AIDS, TB, and malaria-receiving nearly 80% of the total

5 Feb 2009

High-tech hospitals see fewer complications, lower costs

Texas hospitals using health information technologies had fewer complications, lower mortality rates and lower costs, a UT Southwestern Medical Center researcher has found.

3 Feb 2009

New vaccine developed for preventing human adenovirus type-3d virus

Common colds typically cause a week of sneezing, aches and pains and then fade away leaving only a sore nose and a few used sick days behind.

2 Feb 2009

Simple test determines whether children have oropharyngeal dysphagia swallowing disorder

A simple test to swallow three ounces of water can help determine whether a child has the swallowing disorder oropharyngeal dysphagia, establishing for the first time a way to screen for the ailment in children, according to new research published in the February 2009 issue of Otolaryngology - Head and Neck Surgery.

2 Feb 2009

Top hospitals have 27 percent lower mortality: Annual HealthGrades study

Medicare patients treated at top-rated hospitals nationwide across the most common Medicare diagnoses and procedures are 27 percent less likely to die, on average, than those admitted to all other hospitals, according to a study released today by HealthGrades, the leading independent healthcare ratings organization.

29 Jan 2009